Issuer · CIK 0001719406

NRXP — NRX Pharmaceuticals, Inc.

Recent filings

Nov 4, 2026·Form 4·Pro · in 22h 11m$•••K
NRXP/NRX Pharmaceuticals, Inc.
ABRAMS MICHAEL S · Chief Financial Officer
Proonly
Nov 4, 2026·Form 4·Pro · in 22h 10m$•••K
NRXP/NRX Pharmaceuticals, Inc.
Javitt Jonathan C · CEO and Chairman
Proonly

← Back to all filings